Regulation of tumour necrosis factor signalling: live or let die
By D. Brenner, Heiko Blaser, T. Mak. Nature reviews. Immunology, 2015
936 citations recorded by the source corpus.
Subfields: Cancer Research, Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/20af71572e94a569edcc69e7e6162955a739ab82
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Guido Kroemer
- Ralph J. Deberardinis
- M. V. Vander Heiden
- Navdeep S. Chandel
- D. Tang
- L. Galluzzi
- M. Conrad
- Brent R. Stockwell
In Immunology
- Guido Kroemer
- L. Galluzzi
- L. Zitvogel
- Simone Fulda
- Junying Yuan
- Oliver Kepp
- Douglas R. Green
- K. Debatin
In Oncology
Citations in the corpus
- Necroptosis: Mechanisms and Relevance to Disease (2016, neutral): “The ultimate outcome of TNF signaling, however, exhibits an elevated degree of context dependency, ranging from the cytoprotective and proinflammatory activation of NF-κ B-dependent transcriptional programs to RCD via CASP8-and CASP3-mediated apoptosis or RIPK3-and MLKL-dependent necroptosis (55).”
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018, background): “, intensity and duration of TNF stimulation) factors [283].”
- The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics (2021, background): “The activation of TNFR1 can trigger the formation of different signaling complexes, referred to as complexes I, IIa, IIb, and IIc, which result in distinct cellular responses [11,12].”